Eleanor Watson

Eleanor Watson

Auto-generated profile, based on publicly available information

Eleanor Watson

Moredun Research Institute, Bush Loan, Penicuik, United Kingdom

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2012 in Infection and Immunity
Verified
Journal Article
Open access
PDF file
AEAbdi Elmi
Abdi Elmi
EWEleanor Watson
Eleanor Watson
PSPamela Sandu
Pamela Sandu
Ozan GundogduOzan Gundogdu
Ozan Gundogdu
DMDominic C. Mills
Dominic C. Mills
NDNick Dorrell
Nick Dorrell
Campylobacter jejuni is the most prevalent cause of food-borne gastroenteritis in the developed world; however, the molecular basis of pathogenesis is unclear. Secretion of virulence factors is a key mechanism by which enteric bacterial pathogens interact with host cells to enhance survival and/or damage the host. However, C. jejuni lacks the virulence-associated secretion systems possessed by other enteric pathogens. Many bacterial pathogens utilize outer membrane vesicles (OMVs) for delivery of virulence factors into host cells. In the absence of prototypical virulence-associated secretion systems, OMVs could be an important alternative for the coordinated delivery of C. jejuni proteins into host cells. Proteomic analysis of C. jejuni 11168H OMVs identified 151 proteins, including periplasmic and outer membrane-associated proteins, but also many determinants known to be important in survival and pathogenesis, including the cytolethal distending toxin (CDT). C. jejuni OMVs contained 16 N -linked glycoproteins, indicating a delivery mechanism by which these periplasm-located yet immunogenic glycoproteins can interact with host cells. C. jejuni OMVs possess cytotoxic activity and induce a host immune response from T84 intestinal epithelial cells (IECs), which was not reduced by OMV pretreatment with proteinase K or polymyxin B prior to coincubation with IECs. Pretreatment of IECs with methyl-beta-cyclodextrin partially blocks OMV-induced host immune responses, indicating a role for lipid rafts in host cell plasma membranes during interactions with C. jejuni OMVs. OMVs isolated from a C. jejuni 11168H cdtA mutant induced interleukin-8 (IL-8) to the same extent as did wild-type OMVs, suggesting OMV induction of IL-8 is independent of CDT.

31 December 2014 in Molecular Ecology
Verified
Journal Article
Closed access
PDF file
JBJohanna L. Baily
Johanna L. Baily
GMGuillaume Méric
Guillaume Méric
SBSion Ceri Bayliss
Sion Ceri Bayliss
GFGeoffrey Foster
Geoffrey Foster
SMSimon E. Moss
Simon E. Moss
MDMark P. Dagleish
Mark P. Dagleish

1 October 2010 in Microbiology
Verified
Journal Article
Open access
PDF file
GHGraham Haddock
Graham Haddock
MMMargaret Mullin
Margaret Mullin
AMAmanda MacCallum
Amanda MacCallum
ASAileen Sherry
Aileen Sherry
LTLaurence Tetley
Laurence Tetley
PEPaul Everest
Paul Everest
Human small and large intestinal tissue was used to study the interaction of Campylobacter jejuni with its target tissue. The strain used for the study was 81-176 (+pVir). Tissue was processed for scanning and transmission electron microscopy, and by immunohistochemistry for light microscopy. Organisms adhered to the apical surface of ileal tissues at all time points in large numbers, in areas where mucus was present and in distinct groups. Microcolony formation was evident at 1–2 h, with bacteria adhering to mucus on the tissue surface and to each other by flagellar interaction. At later time points (3–4 h), biofilm formation on ileal tissue was evident. Flagellar mutants did not form microcolonies or biofilms in tissue. Few organisms were observed in colonic tissue, with organisms present but not as abundant as in the ileal tissue. This study shows that C. jejuni 81-176 can form microcolonies and biofilms on human intestinal tissue and that this may be an essential step in its ability to cause diarrhoea in man.

1 November 2015 in Vaccine
Verified
Journal Article
Open access
CCCosmin Chintoan-Uta
Cosmin Chintoan-Uta
RCRobin L. Cassady-Cain
Robin L. Cassady-Cain
HAHalah H Al-Haideri
Halah H Al-Haideri
EWEleanor Watson
Eleanor Watson
DKDavid Kelly
David Kelly
MSMark Paul Stevens
Mark Paul Stevens
Campylobacter is the leading cause of foodborne diarrhoeal illness in the developed world and consumption or handling of contaminated poultry meat is the principal source of infection. Strategies to control Campylobacter in broilers prior to slaughter are urgently required and are predicted to limit the incidence of human campylobacteriosis. Towards this aim, a purified recombinant subunit vaccine based on the superoxide dismutase (SodB) protein of C. jejuni M1 was developed and tested in White Leghorn birds. Birds were vaccinated on the day of hatch and 14 days later with SodB fused to glutathione S-transferase (GST) or purified GST alone. Birds were challenged with C. jejuni M1 at 28 days of age and caecal Campylobacter counts determined at weekly intervals. Across three independent trials, the vaccine induced a statistically significant 1 log10 reduction in caecal Campylobacter numbers in vaccinated birds compared to age-matched GST-vaccinated controls. Significant induction of antigen-specific serum IgY was detected in all vaccinated birds, however the magnitude and timing of SodB-specific IgY did not correlate with lower numbers of C. jejuni. Antibodies from SodB-vaccinated chickens detected the protein in the periplasm and not membrane fractions or on the bacterial surface, suggesting that the protection observed may not be strictly antibody-mediated. SodB may be useful as a constituent of vaccines for control of C. jejuni infection in broiler birds, however modest protection was observed late relative to the life of broiler birds and further studies are required to potentiate the magnitude and timing of protection.

10 March 2017 in Scientific Reports
Verified
Journal Article
Open access
PDF file
SVStefan P. W. de Vries
Stefan P. W. de Vries
ALAileen Linn
Aileen Linn
KMKareen Macleod
Kareen Macleod
AMAmanda MacCallum
Amanda MacCallum
SHSimon P. Hardy
Simon P. Hardy
PEPaul Everest
Paul Everest
To investigate howCampylobacter jejunicauses the clinical symptoms of diarrhoeal disease in humans, use of a relevant animal model is essential. Such a model should mimic the human disease closely in terms of host physiology, incubation period before onset of disease, clinical signs and a comparable outcome of disease. In this study, we used a gnotobiotic piglet model to study determinants of pathogenicity ofC. jejuni. In this model,C. jejunisuccessfully established infection and piglets developed an increased temperature with watery diarrhoea, which was caused by a leaky epithelium and reduced bile re-absorption in the intestines. Further, we assessed theC. jejunigenes required for infection of the porcine gastrointestinal tract utilising a transposon (Tn) mutant library screen. A total of 123 genes of which Tn mutants showed attenuated piglet infection were identified. Our screen highlighted a crucial role for motility and chemotaxis, as well as central metabolism. In addition, Tn mutants of 14 genes displayed enhanced piglet infection. This study gives a unique insight into the mechanisms ofC. jejunidisease in terms of host physiology and contributing bacterial factors.

18 November 2009 in Veterinary Microbiology
Verified
Journal Article
Closed access
PAPilar Alberdi
Pilar Alberdi
EWEleanor Watson
Eleanor Watson
GMGina E.M. McAllister
Gina E.M. McAllister
JHJennifer D. Harris
Jennifer D. Harris
EPEdith A. Paxton
Edith A. Paxton
DSDavid G.E. Smith
David G.E. Smith